According to a newly published market research report by 24LifeSciences, global metagenomics sequencing market was valued at USD 910 million in 2024 and is projected to reach USD 1.79 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.4% during the forecast period 20252031. Metagenomics sequencing enables comprehensive...

Genomics is transforming healthcare, enabling researchers and clinicians to understand diseases at a molecular level and deliver personalized treatments. But as sequencing technologies generate larger volumes of data, many organizations face a growing challenge: turning genomic data into reliable, clinically actionable insights. To overcome these challenges, life sciences companies are...

The United States represents a major contributor to the DNA microarray chips market, supported by its advanced biotechnology industry, strong genomic research infrastructure, and increasing adoption of precision medicine. The country is home to numerous pharmaceutical companies, research institutions, and diagnostic laboratories that actively utilize DNA microarray technologies for gene...